RGS10 restricts upregulation by chemokines of T cell adhesion mediated by α4β1 and αLβ2 integrins

Journal of Immunology

Volumn 187, Issue 3, 2011, Pages 1264-1272

  García Bernal, David ^a   Dios Esponera, Ana ^a   Sotillo Mallo, Elena ^a   García Verdugo, Rosa ^a   Arellano Sánchez, Nohemí ^a   Teixidó, Joaquin ^a  

^a CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHALBETA2 INTEGRIN; CHEMOKINE; INTEGRIN; PROTEIN CDC42; RAC1 PROTEIN; RAP1 PROTEIN; RGS PROTEIN; RGS10 PROTEIN; STROMAL CELL DERIVED FACTOR 1; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VERY LATE ACTIVATION ANTIGEN 4;

ARTICLE; CELL ADHESION; CELL SPREADING; CONTROLLED STUDY; HUMAN; HUMAN CELL; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; SHEAR STRESS; T LYMPHOCYTE; UPREGULATION;

ANTIGENS, CD11A; ANTIGENS, CD18; ANTIGENS, CD29; CELL ADHESION; CELLS, CULTURED; CHEMOKINES; CHEMOTAXIS, LEUKOCYTE; DOWN-REGULATION; HUMANS; INTEGRIN ALPHA4; JURKAT CELLS; RGS PROTEINS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; UP-REGULATION;

EID: 80051631548     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1002960     Document Type: Article

References (51)

1. Rossi, D., and A. Zlotnik. 2000. The biology of chemokines and their receptors. Annu. Rev. Immunol. 18: 217-242.
2. Proudfoot, A. E. 2002. Chemokine receptors: multifaceted therapeutic targets. Nat. Rev. Immunol. 2: 106-115. (Pubitemid 37323234)
3. Allen, S. J., S. E. Crown, and T. M. Handel. 2007. Chemokine: receptor structure, interactions, and antagonism. Annu. Rev. Immunol. 25: 787-820. (Pubitemid 46697924)
4. Campbell, D. J., C. H. Kim, and E. C. Butcher. 2003. Chemokines in the systemic organization of immunity. Immunol. Rev. 195: 58-71. (Pubitemid 37153453)
5. Rot, A., and U. H. von Andrian. 2004. Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu. Rev. Immunol. 22: 891-928. (Pubitemid 38680444)
6. Charo, I. F., and R. M. Ransohoff. 2006. The many roles of chemokines and chemokine receptors in inflammation. N. Engl. J. Med. 354: 610-621. (Pubitemid 43209108)
7. Thelen, M., and J. V. Stein. 2008. How chemokines invite leukocytes to dance. Nat. Immunol. 9: 953-959.
8. Luster, A. D., R. Alon, and U. H. von Andrian. 2005. Immune cell migration in inflammation: present and future therapeutic targets. Nat. Immunol. 6: 1182-1190. (Pubitemid 43045626)
9. Ley, K., C. Laudanna, M. I. Cybulsky, and S. Nourshargh. 2007. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat. Rev. Immunol. 7: 678-689. (Pubitemid 47327397)
10. Tadokoro, S., S. J. Shattil, K. Eto, V. Tai, R. C. Liddington, J. M. de Pereda, M. H. Ginsberg, and D. A. Calderwood. 2003. Talin binding to integrin beta tails: a final common step in integrin activation. Science 302: 103-106. (Pubitemid 37210697)
11. Shattil, S. J., C. Kim, and M. H. Ginsberg. 2010. The final steps of integrin activation: the end game. Nat. Rev. Mol. Cell Biol. 11: 288-300.
12. Moser, M., M. Bauer, S. Schmid, R. Ruppert, S. Schmidt, M. Sixt, H. V. Wang, M. Sperandio, and R. Fässler. 2009. Kindlin-3 is required for beta2 integrinmediated leukocyte adhesion to endothelial cells. Nat. Med. 15: 300-305.
13. García-Bernal, D., M. Parmo-Cabañas, A. Dios-Esponera, R. Samaniego, D. Hernán-P de la Ossa, and J. Teixidó. 2009. Chemokine-induced Zap70 kinase-mediated dissociation of the Vav1-talin complex activates alpha4beta1 integrin for T cell adhesion. Immunity 31: 953-964.
14. Shimonaka, M., K. Katagiri, T. Nakayama, N. Fujita, T. Tsuruo, O. Yoshie, and T. Kinashi. 2003. Rap1 translates chemokine signals to integrin activation, cell polarization, and motility across vascular endothelium under flow. J. Cell Biol. 161: 417-427. (Pubitemid 36529858)
15. Katagiri, K., N. Ohnishi, K. Kabashima, T. Iyoda, N. Takeda, Y. Shinkai, K. Inaba, and T. Kinashi. 2004. Crucial functions of the Rap1 effector molecule RAPL in lymphocyte and dendritic cell trafficking. Nat. Immunol. 5: 1045-1051. (Pubitemid 41057724)
16. Offermanns, S. 2001. In vivo functions of heterotrimeric G-proteins: studies in Galpha-deficient mice. Oncogene 20: 1635-1642. (Pubitemid 32336852)
17. Neves, S. R., P. T. Ram, and R. Iyengar. 2002. G protein pathways. Science 296: 1636-1639. (Pubitemid 34579147)
18. Pierce, K. L., R. T. Premont, and R. J. Lefkowitz. 2002. Seven-transmembrane receptors. Nat. Rev. Mol. Cell Biol. 3: 639-650. (Pubitemid 34987785)
19. Kehrl, J. H. 1998. Heterotrimeric G protein signaling: roles in immune function and fine-tuning by RGS proteins. Immunity 8: 1-10. (Pubitemid 28097818)
20. Hollinger, S., and J. R. Hepler. 2002. Cellular regulation of RGS proteins: modulators and integrators of G protein signaling. Pharmacol. Rev. 54: 527-559.
21. Willars, G. B. 2006. Mammalian RGS proteins: multifunctional regulators of cellular signalling. Semin. Cell Dev. Biol. 17: 363-376. (Pubitemid 44066847)
22. Druey, K. M. 2009. Regulation of G-protein-coupled signaling pathways in allergic inflammation. Immunol. Res. 43: 62-76.
23. Heximer, S. P., A. D. Cristillo, and D. R. Forsdyke. 1997. Comparison of mRNA expression of two regulators of G-protein signaling, RGS1/BL34/1R20 and RGS2/G0S8, in cultured human blood mononuclear cells. DNA Cell Biol. 16: 589-598. (Pubitemid 27252971)
24. Scheschonka, A., C. W. Dessauer, S. Sinnarajah, P. Chidiac, C. S. Shi, and J. H. Kehrl. 2000. RGS3 is a GTPase-activating protein for g(ialpha) and g (qalpha) and a potent inhibitor of signaling by GTPase-deficient forms of g (qalpha) and g(11alpha). Mol. Pharmacol. 58: 719-728.
25. Sato, K., H. Kawasaki, C. Morimoto, N. Yamashima, and T. Matsuyama. 2002. An abortive ligand-induced activation of CCR1-mediated downstream signaling event and a deficiency of CCR5 expression are associated with the hyporesponsiveness of human naive CD4+ T cells to CCL3 and CCL5. J. Immunol. 168: 6263-6272. (Pubitemid 34620046)
26. Cho, H., T. Kozasa, K. Takekoshi, J. De Gunzburg, and J. H. Kehrl. 2000. RGS14, a GTPase-activating protein for Gialpha, attenuates Gialpha- and G13alpha-mediated signaling pathways. Mol. Pharmacol. 58: 569-576.
27. Beadling, C., K. M. Druey, G. Richter, J. H. Kehrl, and K. A. Smith. 1999. Regulators of G protein signaling exhibit distinct patterns of gene expression and target G protein specificity in human lymphocytes. J. Immunol. 162: 2677-2682. (Pubitemid 29309289)
28. Hunt, T. W., T. A. Fields, P. J. Casey, and E. G. Peralta. 1996. RGS10 is a selective activator of G alpha i GTPase activity. Nature 383: 175-177. (Pubitemid 26303981)
29. Gold, S. J., Y. G. Ni, H. G. Dohlman, and E. J. Nestler. 1997. Regulators of G-protein signaling (RGS) proteins: region-specific expression of nine subtypes in rat brain. J. Neurosci. 17: 8024-8037. (Pubitemid 27426238)
30. Burgon, P. G., W. L. Lee, A. B. Nixon, E. G. Peralta, and P. J. Casey. 2001. Phosphorylation and nuclear translocation of a regulator of G protein signaling (RGS10). J. Biol. Chem. 276: 32828-32834.
31. García-Bernal, D., N. Wright, E. Sotillo-Mallo, C. Nombela-Arrieta, J. V. Stein, X. R. Bustelo, and J. Teixidó. 2005. Vav1 and Rac control chemokine-promoted T lymphocyte adhesion mediated by the integrin alpha4beta1. Mol. Biol. Cell 16: 3223-3235. (Pubitemid 40962594)
32. Brummelkamp, T. R., R. Bernards, and R. Agami. 2002. A system for stable expression of short interfering RNAs in mammalian cells. Science 296: 550-553. (Pubitemid 34408678)
33. García-Bernal, D., E. Sotillo-Mallo, C. Nombela-Arrieta, R. Samaniego, Y. Fukui, J. V. Stein, and J. Teixidó. 2006. DOCK2 is required for chemokinepromoted human T lymphocyte adhesion under shear stress mediated by the integrin alpha4beta1. J. Immunol. 177: 5215-5225. (Pubitemid 44527594)
34. Sanz-Rodríguez, F., A. Hidalgo, and J. Teixidó. 2001. Chemokine stromal cellderived factor-1alpha modulates VLA-4 integrin-mediated multiple myeloma cell adhesion to CS-1/fibronectin and VCAM-1. Blood 97: 346-351. (Pubitemid 32060316)
35. Stein, J. V., A. Rot, Y. Luo, M. Narasimhaswamy, H. Nakano, M. D. Gunn, A. Matsuzawa, E. J. Quackenbush, M. E. Dorf, and U. H. von Andrian. 2000. The CC chemokine thymus-derived chemotactic agent 4 (TCA-4, secondary lymphoid tissue chemokine, 6Ckine, exodus-2) triggers lymphocyte functionassociated antigen 1-mediated arrest of rolling T lymphocytes in peripheral lymph node high endothelial venules. J. Exp. Med. 191: 61-76.
36. Stein, J. V., S. F. Soriano, C. M'rini, C. Nombela-Arrieta, G. G. de Buitrago, J. M. Rodríguez-Frade, M. Mellado, J. P. Girard, and C. Martínez-A. 2003. CCR7-mediated physiological lymphocyte homing involves activation of a tyrosine kinase pathway. Blood 101: 38-44. (Pubitemid 36025884)
37. Tang, R. H., E. Tng, S. K. Law, and S. M. Tan. 2005. Epitope mapping of monoclonal antibody to integrin alphaL beta2 hybrid domain suggests different requirements of affinity states for intercellular adhesion molecules (ICAM)-1 and ICAM-3 binding. J. Biol. Chem. 280: 29208-29216. (Pubitemid 41161373)
38. Ottoson, N. C., J. T. Pribila, A. S. Chan, and Y. Shimizu. 2001. Cutting edge: T cell migration regulated by CXCR4 chemokine receptor signaling to ZAP-70 tyrosine kinase. J. Immunol. 167: 1857-1861. (Pubitemid 32747487)
39. Ticchioni, M., C. Charvet, N. Noraz, L. Lamy, M. Steinberg, A. Bernard, and M. Deckert. 2002. Signaling through ZAP-70 is required for CXCL12-mediated T-cell transendothelial migration. Blood 99: 3111-3118. (Pubitemid 34525287)
40. Ghandour, H., X. Cullere, A. Alvarez, F. W. Luscinskas, and T. N. Mayadas. 2007. Essential role for Rap1 GTPase and its guanine exchange factor CalDAG-GEFI in LFA-1 but not VLA-4 integrin mediated human T-cell adhesion. Blood 110: 3682-3690. (Pubitemid 350159637)
41. Bos, J. L. 2005. Linking Rap to cell adhesion. Curr. Opin. Cell Biol. 17: 123-128. (Pubitemid 40380934)
42. Bowman, E. P., J. J. Campbell, K. M. Druey, A. Scheschonka, J. H. Kehrl, and E. C. Butcher. 1998. Regulation of chemotactic and proadhesive responses to chemoattractant receptors by RGS (regulator of G-protein signaling) family members. J. Biol. Chem. 273: 28040-28048. (Pubitemid 28496097)
43. Berthebaud, M., C. Rivière, P. Jarrier, A. Foudi, Y. Zhang, D. Compagno, A. Galy, W. Vainchenker, and F. Louache. 2005. RGS16 is a negative regulator of SDF-1-CXCR4 signaling in megakaryocytes. Blood 106: 2962-2968. (Pubitemid 41565886)
44. Reif, K., and J. G. Cyster. 2000. RGS molecule expression in murine B lymphocytes and ability to down-regulate chemotaxis to lymphoid chemokines. J. Immunol. 164: 4720-4729. (Pubitemid 30238073)
45. Abramow-Newerly, M., A. A. Roy, C. Nunn, and P. Chidiac. 2006. RGS proteins have a signalling complex: interactions between RGS proteins and GPCRs, effectors, and auxiliary proteins. Cell. Signal. 18: 579-591. (Pubitemid 43113289)
46. Neitzel, K. L., and J. R. Hepler. 2006. Cellular mechanisms that determine selective RGS protein regulation of G protein-coupled receptor signaling. Semin. Cell Dev. Biol. 17: 383-389. (Pubitemid 44066843)
47. Salim, S., S. Sinnarajah, J. H. Kehrl, and C. W. Dessauer. 2003. Identification of RGS2 and type V adenylyl cyclase interaction sites. J. Biol. Chem. 278: 15842-15849. (Pubitemid 36799699)
48. Chidiac, P., M. E. Gadd, and J. R. Hepler. 2002. Measuring RGS protein interactions with Gq alpha. Methods Enzymol. 344: 686-702.
49. Ouyang, Y. S., Y. Tu, S. A. Barker, and F. Yang. 2003. Regulators of G-protein signaling (RGS) 4, insertion into model membranes and inhibition of activity by phosphatidic acid. J. Biol. Chem. 278: 11115-11122. (Pubitemid 36792664)
50. Willard, F. S., M. D. Willard, A. J. Kimple, M. Soundararajan, E. A. Oestreich, X. Li, N. A. Sowa, R. J. Kimple, D. A. Doyle, C. J. Der, et al. 2009. Regulator of G-protein signaling 14 (RGS14) is a selective H-Ras effector. PLoS ONE 4: e4884.
51. Shu, F. J., S. Ramineni, and J. R. Hepler. 2010. RGS14 is a multifunctional scaffold that integrates G protein and Ras/Raf MAPkinase signalling pathways. Cell. Signal. 22: 366-376.